1.Juergens, SM, Kurland, LT, Okazaki, PH, et al. ALS in Rochester, Minnestoa. 1925–1977. Neurology 1980; 30: 463–470.
2.Forsgren, L, Almay, BGL, Holmgren, G, et al. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983; 68: 20–29.
3.Murros, K, Fogelholm, R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand 1983; 67: 41–47.
4.Hudson, AJ, Davenport, A, Harder, WJ. The incidence of amyotrophic lateral sclerosis in southwestern Ontario, Canada. Neurology 1986; 36: 1524–1528.
5.Boman, K, Meurman, T. Prognosis of amyotrophic lateral sclerosis. Acta Neurol Scand 1967; 43: 489–498.
6.Rosen, AD. Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol 1978; 35: 638–642.
7.Shiraki, HK, Yase, Y. Amyotrophic lateral sclerosis in Japan. In: Vinken, PJ, Bruyn, GW, eds. Handbook of Clinical Neurology, Vol 22. New York: Elsevier Publishing, 1975; 353–419.
8.Gajdusek, DC, Salazar, AM. Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea. Neurology 1982; 32: 107–126.
9.Garruto, RM. Amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam: Clinical, epidemiological, and genetic patterns. Am J Hum Biol 1989; 1: 367–382.
10.Garruto, RM. Cellular and molecular mechanisms of neuronal degeneration: Amyotrophic lateral sclerosis, parkinsonism-dementia and Alzheimer disease. Am J Hum Biol 1989; 1529–653.
11.Hirano, A, Hirano, M,. Dembitzer, HM. Pathological variants and extent of the disease process in amyotrophic lateral sclerosis. In: Hudson, AJ, ed. Amyotrophic Lateral Sclerosis. Concepts in Pathogenesis and Etiology. Toronto: University of Toronto Press, 1990: 166–192.
12.Carpenter, S. Proximal axonal enlargement in motor neuron disease. Neurology 1968; 18: 841–851.
13.Hirano, A. Pathology of amyotrophic lateral sclerosis. In: Gajdusek, DC, Gibbs, CJ Jr., Alpers, M, eds. Slow, Latent and Temperate Virus Infections. National Institutes of Neurological Diseaes and Blindness Monograph No. 2. 1965, pp. 23–27.
14.Hirano, A. Some current concepts on amyotrophic lateral sclerosis. Neurol Med (Tokyo) 1976; 4: 43–51.
15.Chou, SM. Pathognomy of intraneuronal inclusions in ALS. In:. Tsubaki, Y, Toyokura, T, eds. Amyotrophic Lateral Sclerosis. Tokyo: University of Tokyo Press, 1979; 135–176.
16.Hirano, A, Inoue, K. Early pathological changes in amyotrophic lateral sclerosis. Electron microscopic study of chromatolysis, spheroids and Bunina bodies. Neurol Med (Tokyo) 1980; 13: 148–160.
17.Averback, P. Unusual particles in motor neuron disease. Arch Pathol Lab Med 1981; 105: 490–493.
18.Schmidt, ML, Carden, MJ, Lee, VM-Y, et al. Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. Lab Invest 1987; 56: 282–294.
19.Manetto, V, Sternberger, NH, Perry, G, et al. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1988; 47: 642–653.
20.Munoz, DG, Greene, C, Perl, DP, et al. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons in amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol 1988; 47: 243–248.
21.Mizusawa, H, Matsumoto, S, Hirano, A, et al. Abnormal expression of phosphorylated neurofilament proteins in sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1988; 24: 472.
22.Malamud, N, Hirano, A, Kurland, LT. Pathoanatomic changes in amyotrophic lateral sclerosis of Guam. Arch Neurol 1961; 15: 401–415.
23.Hirano, A, Arumugasamy, N, Zimmerman, HM. Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. Arch Neurol 1967; 16: 357–363.
24.Hirano, A, Kurland, LT, Sayre, GP. Familial amyotrophic lateral sclerosis. Arch Neurol 1967; 16: 232–243.
25.Horton, WA, Eldridge, R, Brody, JA. Familial motor neuron disease. Evidence for at least three different types. Neurology 1976; 26: 400–465.
26.Yano, I, Yoshida, S, Uebayashi, Y, et al. Experimental study of degenerative CNS disease in monkeys. In: Abstracts of the International Conference of Amyotrophic Lateral Sclerosis, Kyoto, Japan, October 29–31, 1987; 136.
27.Yase, Y. Metal studies in ALS - further development. In: Tsubaki, T, Yase, Y, eds. Amyotrophic Lateral Sclerosis: Recent Advances in Research and Treatment. Amsterdam: Elsevier Science Publishers, 1988; 59–65.
28.Garruto, RM, Shankar, SK, Yanagihara, R, et al. Low-calcium, high aluminum diet-induced motor neuron pathology in cynomolgus monkeys. Acta Neuropathol (Beri) 1989; 78: 210–219.
29.Strong, MJ, Yanagihara, R, Wolff, AV, et al. Experimental neurofilamentous aggregates: Acute and chronic models of aluminum-induced encephalomyelopathy in rabbits. In: Norris, FB, Rose, FC, eds. Amyotrophic Lateral Sclerosis-New Advances in Toxicology and Epidemiology. London: Smith-Gordon and Company Ltd. 1990; 157–173.
30.Krekoski, CA, Mathew, A, Parhad, IM. Neuronal gene transcription is decreased with aluminum treatment. J Cell Biol 1988; 9: 123–138.
31.Muma, NA, Troncoso, JC, Hoffman, PN, et al. Aluminum neurotoxicity: Altered expression of cytoskeletal genes. Mol Brain Res 1988; 3: 115–122.
32.Parhad, IM, Krekoski, CA, Mathew, A, et al. Neuronal gene expression in aluminum myelopathy. Cell Mol Neurobiol 1989; 9: 123–138.
33.Clark, AW, Tran, PM, Parhad, IM, et al. Neuronal gene expression in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 199; 48: 381.
34.Strong, MJ, Wolff, AV, Wakayama, I, et al. Aluminum-induced chronic myelopathy in rabbits. Neurotoxicology 1991; 12: 9–22.
35.Nerurkar, VR, Strong, MJ, Wakayama, I, et al. Correlation between aluminum dose, clinicopathological changes and neurofilament mRNA expression in aluminum neurotoxicity. Soc Neurosci Abstr 1990; 16: 446.
36.Blanchard, BJ, Ingram, VM. Age-related neurofilament phosphorylation in Alzheimer disease. Neurobiol Aging 1989; 10: 253–259.
37.Sternberger, NA, Sternberger, LA, Ulrich, J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci USA 1985; 82: 4274–4276.
38.Strong, MJ, Garruto, RM. Isolation of fetal mouse motor neurons on discontinuous Percoli density gradients. In Vitro Cell Dev Biol 1989; 25: 939–945.
39.Strong, MJ, Garruto, RM. Aluminum neurotoxicity in vitro: A comparative analysis of dissociated fetal rabbit hippocampal and motor neuron-enriched cultures. Lab Invest 1991, in press.
40.Farnell, BJ, DeBoni, U, Crapper McLachlan, DR. Aluminum neurotoxicity in the absence of neurofibillary degeneration in CAI hippocampal neurons in vitro. Exp Neurol 1982; 78: 241–258.
41.Foy, CD, Chaney, RL, White, MC. The physiology of metal toxicity in plants. Ann Rev Plant Physiol 1978; 29: 511–566.
42.Roy, AK, Sharma, A, Talukder, G. Some aspects of aluminum toxicity in plants. Bot Rev 1988; 54: 145–178.
43.Crapper McLachlan, DR. Aluminum neurotoxicity: criteria for assigning a role in Alzheimer’s disease. In: Lewis, TE, ed. Environmental Chemistry and Toxicology of Aluminum. Michigan: Lewis Publishers, Inc. 1989; 299–315.
44.Joshi, JG. Aluminum, a neurotoxin which affects diverse metabolic reactions. BioFactors 1990; 2: 163–169.
45.Molitoris, BA, Froment, DH, Mackenzie, TA, et al. Citrate, a major factor in the toxicity of orally administered aluminum compounds. Kidney Inter 1989; 36: 949–953.
46.Klein, G, Alfrey, AL, Miller, NL, et al. Aluminum loading during total parenteral nutrition. Am J Clin Nutr 1982; 35: 1425–1429.
47.DeBoni, U, Scott, JW, Crapper, DR. Intracellular aluminum binding: A histochemical study. Histochemistry 1974; 40: 31–37.
48.Karlik, SJ, Eichhorn, GL, Lewis, PN, Crapper, Dr. Interaction of aluminum species with deoxyribonucleic acid. Biochemistry 1980; 19: 5991–5998.
49.Johnson, GVW, Jope, RS. Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. Brain Res 1987; 403: 1–6.
50.Johnson, GVW, Jope, RS. Phosphorylation of rat brain cytoskeletal proteins is increased after orally administered aluminum. Brain Res 1988; 456: 95–103.
51.Johnson, GVW, Xiahua, L, Jope, RS. Aluminum increases agonist-stimulated cyclic AMP production in rat cerebral cortical slices. J Neurochem 1989; 53: 258–263.
52.Pierson, KB, Evenson, MA. 200 Kd Neurofilament protein binds Al, Cu and Zn. Biochem Biophy Res Comm 1988; 152: 598–605.
53.Siegel, N, Haug, A. Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochimica et Biophysica Acta 1983; 744: 36–46.
54.Haug, AR, Caldwell, CR. Aluminum toxicity in plants. The role of plasma membrane and calmoudulin. In: St John, JB, Berlin, I, Jackson, PC, eds. Beltsville Symposia in Agricultural Research. G. Frontiers of membrane Research in Agriculture. Totowa, New Jersey: Rowman & Allanheld, 1985; 359–382.
55.Weis, C, Haug, A. Aluminum-induced conformational changes in calmodulin after the dynamics of interaction with Melittin. Arch Biochem Biophys 1987; 254: 304–312.
56.Putterill, JJ, Gardner, RC. Proteins with potential to protect plants from Al3+ toxicity. Biochimica et Biophysica Acta 1988; 964: 137–145.
57.Bonhaus, DW, McCormack, KM, Mayor, GH, et al. The effects of aluminum on microtubular integrity using in vitro and in vivo models. Toxicol Lett 1980; 6: 141–147.
58.Liwnicz, BH, Kristensson, K, Wisniewski, HM, et al. Observations on axoplasmic transport in rabbits with aluminum-induced neurofibrillary tangles. Brain Res 1974; 80: 413–420.
59.Bates, LA, Boegman, RJ. The functional implications of experimentally produced neurofibillary tangles on axonal transport. Can Fed Biol Sci 1983; 26: 114.
60.Bizzi, A, Crane, R, Yoon, M, et al. The axonal transport of neurofilaments is impaired in aluminum intoxication. J Neuropathol Exp Neurol 1984; 41: 331.
61.Troncoso, JC, Hoffman, PN, Griffin, JW, et al. Aluminum intoxication: a disorder of neurofilament transport in motor neurons. Brain Res 1985; 342: 172–175.
62.Parhad, IM, Griffin, JW, Koves, JF. Aluminum intoxication in the visual system: Morphological and axonal transport studies. Neurology 1984; 34: 197–198.
63.Kosik, KS, McCluskey, AH, Walsh, FX, et al. Axonal transport of cytoskeletal proteins in aluminum toxicity. Neurochem Pathol 1985; 3: 99–108.
64.Wisniewski, HM, Sturman, JA1, Shek, JW. Aluminum chloride induced neurofibrillary changes in the developing rabbit: A chronic animal model. Ann Neurol 1980; 8: 479–490.
65.Uemura, E. Intranuclear aluminum accumulation in chronic animals with experimenal neurofibrillary changes. Exp Neurol 1984; 85: 10–18.
66.Uemura, E, Ireland, WP. Synaptic density in chronic animals with experimental neurofibrillary change. Exp Neurol 1984; 85: 1–9.
67.Bancher, C, Brunner, C, Lassman, H, et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 1989; 477: 90–99.
68.Iqbal, K, Grundke-Iqbal, I, Zaidi, T, et al. Defective brain microtubule assembly in Alzheimer disease. Lancet 1985; 2: 421–426.
